Agomelatine prevented depression in the chronic restraint stress model through enhanced catalase activity and halted oxidative stress.
<h4>Background</h4>Agomelatine (AGO) is an antidepressant with unique pharmacological effects; however, its underlying mechanisms remain unknown. In this study, we examined agomelatine's effects on catalase activity, oxidative stress, and inflammation.<h4>Methods</h4>Chr...
Main Authors: | Jiaxi Xu, Cheng Zhu, Piaopiao Jin, Wangdi Sun, Enyan Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0289248&type=printable |
Similar Items
-
Rubrofusarin Attenuates Chronic Restraint Stress-Induced Depressive Symptoms
by: Jee Hyun Yi, et al.
Published: (2020-05-01) -
The Changes of Expression and Methylation of Genes Involved in Oxidative Stress in Course of Chronic Mild Stress and Antidepressant Therapy with Agomelatine
by: Paulina Wigner, et al.
Published: (2020-06-01) -
Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
by: Andrea C. Rossetti, et al.
Published: (2022-10-01) -
DEPRESSIVE-LIKE SYMPTOMS ARE PRODUCED BY EXCESS GLIOTRANSMISSION IN THE HIPPOCAMPUS AFTER CHRONIC RESTRAINT STRESS
by: Jimmy Stehberg
Published: (2023-10-01) -
Clinical studies on the efficacy of agomelatine on depressive symptoms.
by: Goodwin, G
Published: (2009)